8 April 2016 - Deborah Wilkes
Archived
Pfizer and Allergan have terminated their planned merger after the Department of Treasury and Inland Revenue Service in the US unveiled measures to curb corporate tax inversion deals. Pfizer also announced that it would now decide whether to separate its innovative and established businesses by the end of 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.